NFKB1 and pancreatic neoplasm: Consistent with these findings, we found that the levels of NFκB1 expression in pancreatic cancer CSCs were significantly increased, and ectopic expression of NFκB1 could induce gemcitabine resistance in CSCs and non-CSCs.